Intervention Review

Cerebrolysin for vascular dementia

  1. Ning Chen1,
  2. Mi Yang1,
  3. Jian Guo1,
  4. Muke Zhou1,
  5. Cairong Zhu2,
  6. Li He1,*

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 31 JAN 2013

Assessed as up-to-date: 4 NOV 2012

DOI: 10.1002/14651858.CD008900.pub2

How to Cite

Chen N, Yang M, Guo J, Zhou M, Zhu C, He L. Cerebrolysin for vascular dementia. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD008900. DOI: 10.1002/14651858.CD008900.pub2.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Neurology, Chengdu, Sichuan, China

  2. 2

    School of Public Health, Sichuan University, Epidemic Disease & Health Statistics Department, Sichuan, Chengdu, China

*Li He, Department of Neurology, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China.

Publication History

  1. Publication Status: New
  2. Published Online: 31 JAN 2013


Cited in:


This article has been cited by:

  1. 1
    Terence J. Quinn, In people with vascular dementia, does cerebrolysin improve outcomes compared with placebo?, Cochrane Clinical Answers,